StonvexLoading…
StonvexStonvexStonvexCore line items from DXLG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Annual 2025 2025-02-01 | Annual 2024 2024-02-03 | Annual 2023 2023-01-28 |
|---|---|---|---|---|
Revenue | $435.02M | $467.01M | $521.82M | $545.84M |
Operating Income | $-18.16M | $3.73M | $41.94M | $58.59M |
Net Income | $-35.91M | $3.06M | $27.85M | $89.12M |
EPS (Diluted) | $-0.66 | $0.05 | $0.43 | $1.33 |
Total Assets | $366.95M | $380.95M | $357.74M | $350.60M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $23.81M | $11.90M | $27.59M | $52.07M |
Free Cash Flow OCF − CapEx | $-18.00M | $1.86M | $32.18M | $50.30M |
Shares Outstanding | 54.10M | 59.59M | 64.31M | 66.89M |